| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation elongation factor activity | 2.70e-06 | 20 | 100 | 4 | GO:0003746 | |
| GeneOntologyMolecularFunction | 3 iron, 4 sulfur cluster binding | 7.42e-05 | 3 | 100 | 2 | GO:0051538 | |
| GeneOntologyMolecularFunction | aconitate hydratase activity | 7.42e-05 | 3 | 100 | 2 | GO:0003994 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.68e-04 | 188 | 100 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | NAD binding | 4.95e-04 | 73 | 100 | 4 | GO:0051287 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL9A3 IL16 ADAMTS1 COL20A1 LAMA3 ITGA6 TF ITIH2 COL24A1 ADIPOQ HMCN2 MAMDC2 CSPG4 | 2.94e-07 | 530 | 102 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL9A3 IL16 ADAMTS1 COL20A1 LAMA3 ITGA6 TF ITIH2 COL24A1 ADIPOQ HMCN2 MAMDC2 CSPG4 ALPL | 6.70e-07 | 656 | 102 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL9A3 IL16 ADAMTS1 COL20A1 LAMA3 ITGA6 TF ITIH2 COL24A1 ADIPOQ HMCN2 MAMDC2 CSPG4 ALPL | 6.96e-07 | 658 | 102 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | basal plasma membrane | FRMPD2 ITGA6 SLCO4A1 ITGA3 TF SLC17A5 SLC7A1 SLC8A1 LLGL1 SLC27A1 SLC9B2 | 1.27e-06 | 354 | 102 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | FRMPD2 ITGA6 SLCO4A1 ITGA3 TF SLC17A5 SLC7A1 SLC8A1 LLGL1 SLC27A1 SLC9B2 | 2.39e-06 | 378 | 102 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | FRMPD2 ITGA6 SLCO4A1 ITGA3 SLC17A5 SLC7A1 SLC8A1 LLGL1 SLC9B2 | 2.71e-05 | 320 | 102 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | basement membrane | 2.98e-05 | 122 | 102 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen trimer | 7.12e-05 | 88 | 102 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | somatodendritic compartment | FLNA FLNB CLIP2 ITSN1 GRIK1 TF KLHL20 EEF1A2 PTPN5 SLC8A1 CAMK2N1 HMCN2 PTPRF NRXN1 SV2A KIF5A HNRNPR | 8.82e-05 | 1228 | 102 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | axon | FLNA MYCBP2 ITSN1 GRIK1 ITGA3 KLHL20 PTPN5 SLC8A1 LLGL1 HMCN2 PTPRF NRXN1 KIF5A HNRNPR | 1.07e-04 | 891 | 102 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 1.41e-04 | 4 | 102 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | neuronal cell body | FLNA FLNB ITSN1 GRIK1 EEF1A2 PTPN5 SLC8A1 CAMK2N1 HMCN2 PTPRF NRXN1 SV2A KIF5A | 2.11e-04 | 835 | 102 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.23e-04 | 332 | 102 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | anchoring junction | FLNA FLNB IL16 FRMPD2 LAMA3 ITGA6 ITGA3 LAP3 SLC8A1 LLGL1 NRXN1 SV2A CSPG4 FHL3 | 2.75e-04 | 976 | 102 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | distal axon | 2.80e-04 | 435 | 102 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.20e-04 | 443 | 102 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | cell cortex | 4.69e-04 | 371 | 102 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | apical dendrite | 5.05e-04 | 32 | 102 | 3 | GO:0097440 | |
| GeneOntologyCellularComponent | cell body | FLNA FLNB ITSN1 GRIK1 EEF1A2 PTPN5 SLC8A1 CAMK2N1 HMCN2 PTPRF NRXN1 SV2A KIF5A | 5.83e-04 | 929 | 102 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | myelin sheath | 6.87e-04 | 217 | 102 | 6 | GO:0043209 | |
| GeneOntologyCellularComponent | dendrite | FLNA CLIP2 ITSN1 GRIK1 TF KLHL20 PTPN5 SLC8A1 CAMK2N1 SV2A KIF5A HNRNPR | 9.63e-04 | 858 | 102 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FLNA CLIP2 ITSN1 GRIK1 TF KLHL20 PTPN5 SLC8A1 CAMK2N1 SV2A KIF5A HNRNPR | 9.83e-04 | 860 | 102 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | focal adhesion | 1.24e-03 | 431 | 102 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.26e-03 | 11 | 102 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | presynapse | ITSN1 GRIK1 ITGA3 SLC18B1 PTPN5 SLC17A5 SLC8A1 PTPRD NRXN1 SV2A SLC9B2 HNRNPR | 1.27e-03 | 886 | 102 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | growth cone | 1.29e-03 | 245 | 102 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.51e-03 | 253 | 102 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | cytoplasmic side of lysosomal membrane | 2.06e-03 | 14 | 102 | 2 | GO:0098574 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.68e-03 | 118 | 102 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.01e-03 | 59 | 102 | 3 | GO:0098636 | |
| HumanPheno | Urethral stenosis | 4.87e-05 | 57 | 37 | 5 | HP:0008661 | |
| HumanPheno | Accessory carpal bones | 5.13e-05 | 2 | 37 | 2 | HP:0004232 | |
| HumanPheno | Bipartite calcaneus | 5.13e-05 | 2 | 37 | 2 | HP:0008127 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | COL4A2 FLNA MYCBP2 LAMA3 ITGA6 ITGA3 TF SLC17A5 SLC7A1 CLIP3 LLGL1 PAX8 SV2A DHCR7 EPC1 B9D1 KIF5A MBD5 HYDIN ALPL NOVA1 | 2.03e-05 | 1269 | 86 | 21 | MP:0011111 |
| Domain | Transl_elong_EFTu/EF1A_C | 8.18e-06 | 8 | 100 | 3 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 8.18e-06 | 8 | 100 | 3 | PF03143 | |
| Domain | G_TR_CS | 1.22e-05 | 9 | 100 | 3 | IPR031157 | |
| Domain | Laminin_G | 1.46e-05 | 58 | 100 | 5 | IPR001791 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.74e-05 | 10 | 100 | 3 | IPR009001 | |
| Domain | Filamin | 2.38e-05 | 11 | 100 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.38e-05 | 11 | 100 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.38e-05 | 11 | 100 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.38e-05 | 11 | 100 | 3 | IPR017868 | |
| Domain | Transl_elong_EF1A_euk/arc | 2.84e-05 | 2 | 100 | 2 | IPR004539 | |
| Domain | G_TR_1 | 4.10e-05 | 13 | 100 | 3 | PS00301 | |
| Domain | LAM_G_DOMAIN | 4.97e-05 | 38 | 100 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 6.10e-05 | 40 | 100 | 4 | PF02210 | |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 8.48e-05 | 3 | 100 | 2 | IPR000573 | |
| Domain | Aconitase_C | 8.48e-05 | 3 | 100 | 2 | PF00694 | |
| Domain | - | 8.48e-05 | 3 | 100 | 2 | 3.30.499.10 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 8.48e-05 | 3 | 100 | 2 | IPR001030 | |
| Domain | - | 8.48e-05 | 3 | 100 | 2 | 3.40.1060.10 | |
| Domain | - | 8.48e-05 | 3 | 100 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 8.48e-05 | 3 | 100 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 8.48e-05 | 3 | 100 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 8.48e-05 | 3 | 100 | 2 | IPR015932 | |
| Domain | ACONITASE_1 | 8.48e-05 | 3 | 100 | 2 | PS00450 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 8.48e-05 | 3 | 100 | 2 | IPR015928 | |
| Domain | Aconitase | 8.48e-05 | 3 | 100 | 2 | PF00330 | |
| Domain | Aconitase_4Fe-4S_BS | 8.48e-05 | 3 | 100 | 2 | IPR018136 | |
| Domain | ACONITASE_2 | 8.48e-05 | 3 | 100 | 2 | PS01244 | |
| Domain | Collagen | 9.30e-05 | 85 | 100 | 5 | IPR008160 | |
| Domain | Collagen | 9.30e-05 | 85 | 100 | 5 | PF01391 | |
| Domain | EFTu-like_2 | 1.15e-04 | 18 | 100 | 3 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 1.15e-04 | 18 | 100 | 3 | PF03144 | |
| Domain | G_TR_2 | 1.15e-04 | 18 | 100 | 3 | PS51722 | |
| Domain | TF_GTP-bd_dom | 1.36e-04 | 19 | 100 | 3 | IPR000795 | |
| Domain | Ig_E-set | 2.41e-04 | 104 | 100 | 5 | IPR014756 | |
| Domain | PHR | 2.81e-04 | 5 | 100 | 2 | IPR012983 | |
| Domain | PHR | 2.81e-04 | 5 | 100 | 2 | PF08005 | |
| Domain | Transl_B-barrel | 3.97e-04 | 27 | 100 | 3 | IPR009000 | |
| Domain | PTPc | 9.35e-04 | 36 | 100 | 3 | SM00194 | |
| Domain | ConA-like_dom | 1.16e-03 | 219 | 100 | 6 | IPR013320 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.18e-03 | 39 | 100 | 3 | PS50055 | |
| Domain | IG_FLMN | 1.24e-03 | 10 | 100 | 2 | SM00557 | |
| Domain | CAP_GLY | 1.24e-03 | 10 | 100 | 2 | PF01302 | |
| Domain | CAP_GLY | 1.24e-03 | 10 | 100 | 2 | SM01052 | |
| Domain | - | 1.24e-03 | 10 | 100 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 1.24e-03 | 10 | 100 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.24e-03 | 10 | 100 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.24e-03 | 10 | 100 | 2 | IPR000938 | |
| Domain | PTPase_domain | 1.37e-03 | 41 | 100 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.37e-03 | 41 | 100 | 3 | PF00102 | |
| Domain | Ig-like_fold | FLNA FLNB MYCBP2 COL20A1 MST1R HMCN2 PTPRD PTPRF PKHD1 ADGRF3 TREML1 | 1.39e-03 | 706 | 100 | 11 | IPR013783 |
| Domain | LamG | 1.68e-03 | 44 | 100 | 3 | SM00282 | |
| Domain | - | 1.70e-03 | 95 | 100 | 4 | 2.60.120.200 | |
| Domain | MFS | 2.71e-03 | 108 | 100 | 4 | PS50850 | |
| Domain | Integrin_alpha_C_CS | 3.24e-03 | 16 | 100 | 2 | IPR018184 | |
| Domain | PTPc_motif | 3.90e-03 | 59 | 100 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.90e-03 | 59 | 100 | 3 | IPR003595 | |
| Domain | BACK | 4.09e-03 | 60 | 100 | 3 | SM00875 | |
| Domain | Integrin_alpha-2 | 4.11e-03 | 18 | 100 | 2 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 4.11e-03 | 18 | 100 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 4.11e-03 | 18 | 100 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.11e-03 | 18 | 100 | 2 | IPR000413 | |
| Domain | BACK | 4.28e-03 | 61 | 100 | 3 | IPR011705 | |
| Domain | BACK | 4.28e-03 | 61 | 100 | 3 | PF07707 | |
| Domain | Int_alpha | 4.57e-03 | 19 | 100 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 4.57e-03 | 19 | 100 | 2 | IPR013519 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.80e-07 | 90 | 82 | 7 | M631 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.38e-06 | 61 | 82 | 6 | M27103 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL9A3 ADAMTS1 COL20A1 LAMA3 ITGA6 ITGA3 COL24A1 NRXN1 TLL2 | 9.06e-06 | 300 | 82 | 10 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.60e-05 | 30 | 82 | 4 | M27216 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.29e-05 | 67 | 82 | 5 | M26999 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.21e-05 | 15 | 82 | 3 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.21e-05 | 15 | 82 | 3 | MM14922 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.21e-04 | 44 | 82 | 4 | M27812 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.27e-04 | 84 | 82 | 5 | M7098 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.79e-04 | 59 | 82 | 4 | M27218 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.31e-04 | 61 | 82 | 4 | MM14637 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.83e-04 | 66 | 82 | 4 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.88e-04 | 30 | 82 | 3 | M27772 | |
| Pathway | KEGG_CITRATE_CYCLE_TCA_CYCLE | 7.58e-04 | 31 | 82 | 3 | M3985 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COL4A2 FLNA FLNB MYCBP2 ACO1 ACO2 POLR2A TMEM14C TUFM EEF1A1 EEF1A2 PDIA6 DHCR7 AHCY DLD HYDIN | 2.09e-09 | 807 | 103 | 16 | 30575818 |
| Pubmed | 3.85e-08 | 167 | 103 | 8 | 22159717 | ||
| Pubmed | FLNB CLIP2 MYCBP2 ADAMTS1 ACO1 ITSN1 GRIK1 BTBD2 TF ME3 EEF1A1 EEF1A2 PTPRD GLUD1 AHCY MAP3K11 KIF5A ALPL | 4.11e-08 | 1285 | 103 | 18 | 35914814 | |
| Pubmed | Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. | 5.82e-08 | 116 | 103 | 7 | 27576135 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FLNA FLNB MYCBP2 ITSN1 TMEM14C BTBD2 LAP3 EEF1A1 AHCY KIF5A FHL3 HNRNPR | 1.09e-07 | 560 | 103 | 12 | 21653829 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA MGAT4B RAPGEF6 MYCBP2 POLR2A KHNYN SLCO4A1 ITGA3 TEP1 MST1R SLC7A1 PTPRF CLCN7 CSPG4 MAP3K11 MBD5 | 1.63e-07 | 1105 | 103 | 16 | 35748872 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYCBP2 POLR2A FARSB TUFM NDUFA11 EEF1A1 EEF1A1P5 EEF1A2 HIGD1A PDIA6 G3BP2 DHCR7 GLUD1 AHCY DLD YTHDF2 HNRNPR | 1.68e-07 | 1257 | 103 | 17 | 37317656 |
| Pubmed | 1.74e-07 | 203 | 103 | 8 | 35012549 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FLNA ACO2 POLR2A TUFM EEF1A1 PDIA6 G3BP2 GLUD1 AHCY PRPF38A YTHDF2 TOP2A HNRNPR | 2.03e-07 | 714 | 103 | 13 | 28302793 |
| Pubmed | FLNA FLNB IL16 CLIP2 ACO2 ITSN1 FARSB TF TUFM EEF1A1 EEF1A2 PDIA6 SV2A G3BP2 SLC27A1 GLUD1 DLD HNRNPR | 2.04e-07 | 1431 | 103 | 18 | 37142655 | |
| Pubmed | FLNA FLNB COL20A1 ACO2 ITSN1 TUFM EEF1A1 EEF1A2 PDIA6 NRXN1 SLC27A1 CSPG4 GLUD1 PKHD1 DLD KIF5A TOP2A HNRNPR | 2.28e-07 | 1442 | 103 | 18 | 35575683 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNB MYCBP2 ADAMTS1 KHNYN FARSB LAP3 TUFM EEF1A1 EEF1A2 PDIA6 G3BP2 GLUD1 AHCY YTHDF2 HNRNPR | 2.75e-07 | 1149 | 103 | 16 | 35446349 |
| Pubmed | FLNA FLNB ACO2 FARSB ITGA3 LAP3 TUFM EEF1A1 PDIA6 DHCR7 AHCY TOP2A HNRNPR | 7.62e-07 | 803 | 103 | 13 | 36517590 | |
| Pubmed | 7.92e-07 | 248 | 103 | 8 | 32963011 | ||
| Pubmed | 8.35e-07 | 58 | 103 | 5 | 15952740 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.01e-06 | 256 | 103 | 8 | 24189400 | |
| Pubmed | NOL4 IL16 ADAMTS1 POLR2A ITGA3 TEP1 TF TUFM HMCN2 SV2A EPC1 LTN1 FHL3 TOP2A ALPL | 1.05e-06 | 1116 | 103 | 15 | 31753913 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA FLNB FARSB TF NDUFA11 PTPN5 PDIA6 PTPRD PTPRF GLUD1 LTN1 DLD KIF5A FHL3 | 1.13e-06 | 974 | 103 | 14 | 28675297 |
| Pubmed | FLNA FLNB ACO2 FARSB TUFM EEF1A1 PDIA6 GLUD1 DLD YTHDF2 TOP2A HNRNPR | 1.28e-06 | 707 | 103 | 12 | 19738201 | |
| Pubmed | FLNA FLNB FARSB TUFM EEF1A1 EEF1A1P5 EEF1A2 PDIA6 GLUD1 AHCY YTHDF2 TOP2A HNRNPR | 1.32e-06 | 844 | 103 | 13 | 25963833 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 37591863 | ||
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 8725284 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 1.96e-06 | 607 | 103 | 11 | 39147351 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNB MYCBP2 ACO2 POLR2A FARSB DDX51 TUFM PDIA6 LLGL1 LTN1 AHCY PRPF38A YTHDF2 TOP2A HNRNPR | 2.33e-06 | 1353 | 103 | 16 | 29467282 |
| Pubmed | 2.45e-06 | 32 | 103 | 4 | 23154389 | ||
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 10811835 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA FLNB ACO2 POLR2A FARSB LAP3 TUFM EEF1A1 PDIA6 G3BP2 DHCR7 GLUD1 AHCY DLD TOP2A HNRNPR | 4.52e-06 | 1425 | 103 | 16 | 30948266 |
| Pubmed | 4.99e-06 | 83 | 103 | 5 | 35124280 | ||
| Pubmed | 5.80e-06 | 551 | 103 | 10 | 34728620 | ||
| Pubmed | 5.89e-06 | 552 | 103 | 10 | 36293380 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 6.47e-06 | 558 | 103 | 10 | 35063084 | |
| Pubmed | 7.43e-06 | 90 | 103 | 5 | 31280863 | ||
| Pubmed | 7.50e-06 | 239 | 103 | 7 | 26641092 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | POLR2A FARSB LAP3 TUFM G3BP2 LTN1 AHCY PRPF38A FHL3 YTHDF2 TOP2A | 7.99e-06 | 704 | 103 | 11 | 29955894 |
| Pubmed | 8.28e-06 | 92 | 103 | 5 | 37343697 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23415882 | ||
| Pubmed | Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. | 8.69e-06 | 2 | 103 | 2 | 1946438 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18209063 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17635842 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 8.69e-06 | 2 | 103 | 2 | 30782564 | |
| Pubmed | Anatomy of a viral entry platform differentially functionalized by integrins α3 and α6. | 8.69e-06 | 2 | 103 | 2 | 32210347 | |
| Pubmed | The laminin binding α3 and α6 integrins cooperate to promote epithelial cell adhesion and growth. | 8.69e-06 | 2 | 103 | 2 | 30193894 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16480904 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7665159 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 35741005 | ||
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 8.69e-06 | 2 | 103 | 2 | 21325628 | |
| Pubmed | The aconitase family: three structural variations on a common theme. | 8.69e-06 | 2 | 103 | 2 | 9020582 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15840581 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 8.69e-06 | 2 | 103 | 2 | 30370994 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26212729 | ||
| Pubmed | Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells. | 8.69e-06 | 2 | 103 | 2 | 27509031 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7516184 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17825975 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11988844 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22095224 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11336782 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33649519 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 38220433 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19636410 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9950675 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17377140 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7945283 | ||
| Pubmed | Regional localization of the genes coding for human ACO2, ARSA, and NAGA on chromosome 22. | 8.69e-06 | 2 | 103 | 2 | 7192199 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32347192 | ||
| Pubmed | 8.81e-06 | 245 | 103 | 7 | 21182205 | ||
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 12919677 | ||
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 24811271 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 9.06e-06 | 580 | 103 | 10 | 35676659 | |
| Pubmed | ACO2 TMEM14C ITGA6 TF LAP3 TUFM NDUFA11 EEF1A1 PTPRD DHCR7 GLUD1 DLD | 9.33e-06 | 859 | 103 | 12 | 31536960 | |
| Pubmed | 1.01e-05 | 463 | 103 | 9 | 34901782 | ||
| Pubmed | 1.03e-05 | 251 | 103 | 7 | 28077445 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.05e-05 | 166 | 103 | 6 | 35687106 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB MYCBP2 POLR2A TUFM EEF1A1 PDIA6 PTPRF DHCR7 GLUD1 AHCY TOP2A HNRNPR | 1.07e-05 | 1024 | 103 | 13 | 24711643 |
| Pubmed | 1.08e-05 | 46 | 103 | 4 | 33403043 | ||
| Pubmed | 1.12e-05 | 15 | 103 | 3 | 8812466 | ||
| Pubmed | FLNA FLNB LAP3 NDUFA11 EEF1A1 EEF1A1P5 EEF1A2 HIGD1A PDIA6 DHCR7 AHCY DLD | 1.16e-05 | 878 | 103 | 12 | 37223481 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.28e-05 | 477 | 103 | 9 | 31300519 | |
| Pubmed | 1.37e-05 | 16 | 103 | 3 | 17601529 | ||
| Pubmed | 1.43e-05 | 484 | 103 | 9 | 31995728 | ||
| Pubmed | 1.53e-05 | 488 | 103 | 9 | 31324722 | ||
| Pubmed | Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways. | 1.62e-05 | 179 | 103 | 6 | 18624398 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | COL4A2 FLNA FLNB ACO1 LAMA3 TF LAP3 ITIH2 ARSA PTPRD CSPG4 AHCY ALPL | 1.70e-05 | 1070 | 103 | 13 | 23533145 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 1.71e-05 | 495 | 103 | 9 | 28581483 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA FLNB ITSN1 TUFM EEF1A1 EEF1A1P5 G3BP2 DHCR7 TOP2A HNRNPR | 1.75e-05 | 626 | 103 | 10 | 33644029 |
| Pubmed | 1.89e-05 | 382 | 103 | 8 | 37249651 | ||
| Pubmed | FLNA ACO2 POLR2A FARSB TUFM EEF1A1 G3BP2 DHCR7 GLUD1 AHCY DLD FHL3 TOP2A HNRNPR | 1.90e-05 | 1247 | 103 | 14 | 27684187 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOL4 MYCBP2 ACO2 POLR2A TUFM EEF1A1 PDIA6 LLGL1 NRXN1 MAMDC2 DHCR7 PRPF38A HNRNPR | 1.91e-05 | 1082 | 103 | 13 | 38697112 |
| Pubmed | 1.99e-05 | 18 | 103 | 3 | 36877072 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.99e-05 | 18 | 103 | 3 | 12119179 | |
| Pubmed | 1.99e-05 | 18 | 103 | 3 | 27984743 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA FLNB LAMA3 ITGA6 FARSB ITIH2 TUFM EEF1A1 G3BP2 GLUD1 AHCY YTHDF2 TOP2A HNRNPR | 2.07e-05 | 1257 | 103 | 14 | 36526897 |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 2.25e-05 | 113 | 103 | 5 | 34474245 | |
| Pubmed | 2.25e-05 | 113 | 103 | 5 | 30352685 | ||
| Pubmed | 2.33e-05 | 191 | 103 | 6 | 33762435 | ||
| Pubmed | 2.33e-05 | 285 | 103 | 7 | 21423176 | ||
| Pubmed | 2.36e-05 | 19 | 103 | 3 | 16319112 | ||
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 2.44e-05 | 287 | 103 | 7 | 36180891 | |
| Pubmed | 2.47e-05 | 652 | 103 | 10 | 31180492 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 2.50e-05 | 288 | 103 | 7 | 31501420 | |
| Pubmed | 2.50e-05 | 288 | 103 | 7 | 38496616 | ||
| Interaction | FER1L6 interactions | 4.34e-06 | 7 | 102 | 3 | int:FER1L6 | |
| Interaction | AGR2 interactions | COL4A2 FLNA FLNB MYCBP2 ACO1 ACO2 POLR2A TMEM14C TUFM EEF1A1 EEF1A2 PDIA6 DHCR7 AHCY DLD HYDIN | 1.79e-05 | 934 | 102 | 16 | int:AGR2 |
| Interaction | DTX3 interactions | 1.83e-05 | 108 | 102 | 6 | int:DTX3 | |
| Interaction | BMP1 interactions | 2.14e-05 | 111 | 102 | 6 | int:BMP1 | |
| Interaction | RAC1 interactions | FLNA FLNB TMEM14C ITGA6 SLCO4A1 FARSB ITGA3 EEF1A1 HIGD1A SLC7A1 LLGL1 PTPRF CLCN7 DHCR7 MAP3K11 TOP2A ALPL | 2.29e-05 | 1063 | 102 | 17 | int:RAC1 |
| Interaction | FN1 interactions | COL4A2 FLNA FLNB FARSB ITGA3 TF ITIH2 TUFM EEF1A1 PDIA6 GLUD1 DLD YTHDF2 TOP2A HNRNPR | 2.32e-05 | 848 | 102 | 15 | int:FN1 |
| Interaction | LGALS8 interactions | 2.94e-05 | 174 | 102 | 7 | int:LGALS8 | |
| Interaction | HPX interactions | 3.44e-05 | 73 | 102 | 5 | int:HPX | |
| Interaction | GPC1 interactions | 3.52e-05 | 179 | 102 | 7 | int:GPC1 | |
| Interaction | FCER1A interactions | 3.59e-05 | 37 | 102 | 4 | int:FCER1A | |
| Interaction | LGALS9 interactions | FLNA FLNB FARSB TUFM EEF1A1 SLC17A5 SLC7A1 PDIA6 DHCR7 CSPG4 AHCY TOP2A | 4.21e-05 | 588 | 102 | 12 | int:LGALS9 |
| Interaction | CLUH interactions | 5.76e-05 | 263 | 102 | 8 | int:CLUH | |
| Interaction | PTEN interactions | FLNA FLNB ACO2 POLR2A ITGA6 FARSB TUFM EEF1A2 PDIA6 G3BP2 GLUD1 AHCY DLD ADGRF3 YTHDF2 | 6.59e-05 | 929 | 102 | 15 | int:PTEN |
| Interaction | FBXO6 interactions | COL4A2 LAMA3 ITGA6 ITGA3 TUFM EEF1A1 MST1R PDIA6 CSPG4 AHCY YTHDF2 ALPL HNRNPR | 6.66e-05 | 717 | 102 | 13 | int:FBXO6 |
| Interaction | KCTD10 interactions | 6.67e-05 | 198 | 102 | 7 | int:KCTD10 | |
| Interaction | ZMYM6 interactions | 6.77e-05 | 84 | 102 | 5 | int:ZMYM6 | |
| Interaction | ADARB2 interactions | 8.13e-05 | 17 | 102 | 3 | int:ADARB2 | |
| Interaction | TOP3B interactions | FLNA MGAT4B RAPGEF6 MYCBP2 POLR2A KHNYN SLCO4A1 ITGA3 TEP1 TUFM MST1R SLC7A1 PTPRF CLCN7 G3BP2 CSPG4 MAP3K11 MBD5 YTHDF2 | 1.30e-04 | 1470 | 102 | 19 | int:TOP3B |
| Interaction | ACE2 interactions | FLNA FLNB FARSB ITGA3 TUFM EEF1A1 EEF1A1P5 EEF1A2 PDIA6 PTPRD PTPRF G3BP2 AHCY YTHDF2 TOP2A HNRNPR | 1.34e-04 | 1106 | 102 | 16 | int:ACE2 |
| Interaction | VCAM1 interactions | 1.48e-04 | 475 | 102 | 10 | int:VCAM1 | |
| Interaction | CD81 interactions | 1.54e-04 | 303 | 102 | 8 | int:CD81 | |
| Interaction | GART interactions | 1.70e-04 | 230 | 102 | 7 | int:GART | |
| Interaction | C8A interactions | 1.81e-04 | 22 | 102 | 3 | int:C8A | |
| Interaction | ACAN interactions | 1.81e-04 | 22 | 102 | 3 | int:ACAN | |
| Interaction | RAPGEF2 interactions | 1.95e-04 | 105 | 102 | 5 | int:RAPGEF2 | |
| Interaction | KCTD13 interactions | FLNA FLNB IL16 CLIP2 ACO2 ITSN1 FARSB TF TUFM EEF1A1 EEF1A2 PDIA6 SV2A G3BP2 SLC27A1 GLUD1 DLD HNRNPR | 2.03e-04 | 1394 | 102 | 18 | int:KCTD13 |
| Interaction | EEF1A2 interactions | 2.05e-04 | 316 | 102 | 8 | int:EEF1A2 | |
| Cytoband | 1p36.12 | 9.45e-05 | 39 | 103 | 3 | 1p36.12 | |
| Cytoband | 20q13.3 | 9.22e-04 | 20 | 103 | 2 | 20q13.3 | |
| Cytoband | 15q24.2 | 2.37e-03 | 32 | 103 | 2 | 15q24.2 | |
| Cytoband | 1p34 | 2.37e-03 | 32 | 103 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q21 | 2.67e-03 | 122 | 103 | 3 | chr21q21 | |
| GeneFamily | Collagens | 2.81e-05 | 46 | 69 | 4 | 490 | |
| GeneFamily | Solute carriers | 7.58e-04 | 395 | 69 | 7 | 752 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.11e-03 | 18 | 69 | 2 | 1160 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.88e-03 | 21 | 69 | 2 | 813 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 9.78e-07 | 193 | 103 | 8 | M6813 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.10e-06 | 196 | 103 | 8 | MM667 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.23e-06 | 199 | 103 | 8 | M5893 | |
| Coexpression | NABA_CORE_MATRISOME | 1.17e-05 | 270 | 103 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.33e-05 | 275 | 103 | 8 | M5884 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.37e-05 | 276 | 103 | 8 | M3063 | |
| Coexpression | HALLMARK_ADIPOGENESIS | 1.45e-05 | 200 | 103 | 7 | M5905 | |
| Coexpression | NABA_COLLAGENS | 2.47e-05 | 43 | 103 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.71e-05 | 44 | 103 | 4 | M3005 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 4.32e-05 | 98 | 103 | 5 | M40018 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 7.02e-05 | 176 | 103 | 6 | M39223 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 7.83e-05 | 111 | 103 | 5 | M45685 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | FLNB MGAT4B COL9A3 IL16 LAMA3 ITGA6 ITGA3 PTPRF DHCR7 B9D1 MAP3K11 | 1.03e-04 | 704 | 103 | 11 | M45672 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NOL4 RAPGEF6 MYCBP2 LAMA3 GRIK1 EEF1A2 PTPN5 ARFGEF3 SLC8A1 CAMK2N1 NRXN1 SV2A HYDIN NOVA1 | 1.08e-04 | 1106 | 103 | 14 | M39071 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.30e-04 | 197 | 103 | 6 | M7458 | |
| Coexpression | GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP | 1.34e-04 | 198 | 103 | 6 | M3253 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP | 1.34e-04 | 198 | 103 | 6 | M3596 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.38e-04 | 199 | 103 | 6 | M6612 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP | 1.42e-04 | 200 | 103 | 6 | M3514 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.42e-04 | 200 | 103 | 6 | M8632 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.42e-04 | 126 | 103 | 5 | M39132 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN | 1.61e-04 | 27 | 103 | 3 | M5570 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL9A3 IL16 ADAMTS1 COL20A1 LAMA3 ITIH2 COL24A1 ADIPOQ HMCN2 TLL2 CSPG4 TNFAIP6 | 1.62e-04 | 1008 | 103 | 13 | MM17056 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 1.69e-04 | 70 | 103 | 4 | M40002 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | RAPGEF6 TMEM14C KLHL20 NDUFA11 HIGD1A SLC7A1 PDIA6 G3BP2 GLUD1 YTHDF2 TOP2A HNRNPR | 1.71e-04 | 877 | 103 | 12 | M2241 |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.79e-04 | 71 | 103 | 4 | M2948 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL9A3 IL16 ADAMTS1 COL20A1 LAMA3 ITIH2 COL24A1 ADIPOQ HMCN2 TLL2 CSPG4 TNFAIP6 | 1.93e-04 | 1026 | 103 | 13 | M5889 |
| CoexpressionAtlas | cerebral cortex | NOL4 COL9A3 CLIP2 COL20A1 FRMPD2 GRIK1 EEF1A2 PTPN5 ARFGEF3 CLIP3 CAMK2N1 LLGL1 PTPRD NRXN1 SV2A TLL2 SLC9B2 KCNS2 KIF5A NOVA1 | 1.10e-05 | 1428 | 101 | 20 | cerebral cortex |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-10 | 184 | 103 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-10 | 184 | 103 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-10 | 184 | 103 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.94e-07 | 178 | 103 | 7 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.81e-07 | 188 | 103 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.63e-06 | 168 | 103 | 6 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-06 | 173 | 103 | 6 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 3.32e-06 | 175 | 103 | 6 | f6663e5a9c87e27f3459a6481768b03aff7d0855 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.44e-06 | 176 | 103 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.44e-06 | 176 | 103 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 3.67e-06 | 178 | 103 | 6 | bb5dc22f6bcde1ce29598ae4e839e98a7caa07b6 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 178 | 103 | 6 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 181 | 103 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 5.02e-06 | 188 | 103 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-06 | 191 | 103 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 5.50e-06 | 191 | 103 | 6 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.01e-06 | 194 | 103 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 6.19e-06 | 195 | 103 | 6 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-06 | 197 | 103 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.56e-06 | 197 | 103 | 6 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-06 | 198 | 103 | 6 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-06 | 199 | 103 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-06 | 199 | 103 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-06 | 200 | 103 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.15e-06 | 200 | 103 | 6 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 7.15e-06 | 200 | 103 | 6 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 161 | 103 | 5 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 161 | 103 | 5 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.64e-05 | 161 | 103 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 161 | 103 | 5 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 161 | 103 | 5 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-05 | 167 | 103 | 5 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 172 | 103 | 5 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | b413a8554868e3c09275948b6605f7dc7f7277fd | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 5.12e-05 | 173 | 103 | 5 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.26e-05 | 174 | 103 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.26e-05 | 174 | 103 | 5 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 5.41e-05 | 175 | 103 | 5 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 177 | 103 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-05 | 177 | 103 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 5.71e-05 | 177 | 103 | 5 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 179 | 103 | 5 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 179 | 103 | 5 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 6.02e-05 | 179 | 103 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 6.02e-05 | 179 | 103 | 5 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 179 | 103 | 5 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-05 | 180 | 103 | 5 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 181 | 103 | 5 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 181 | 103 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-05 | 182 | 103 | 5 | d6740bca2b974122b8451989365a94a81140afd1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-05 | 182 | 103 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-05 | 182 | 103 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 6.51e-05 | 182 | 103 | 5 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.68e-05 | 183 | 103 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 6.68e-05 | 183 | 103 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 103 | 5 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 103 | 5 | eb1f1dd12d1e4f1a7029b5396baada23f7c971ff | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 103 | 5 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.86e-05 | 184 | 103 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-05 | 185 | 103 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 185 | 103 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 185 | 103 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 185 | 103 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.04e-05 | 185 | 103 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-05 | 185 | 103 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | LAM-Lymphoid-B-cell-2|Lymphoid / Condition, Lineage and Cell class | 7.22e-05 | 186 | 103 | 5 | bcfe0bf2f7f745146b74496a4fcfccd869ad7c6f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 186 | 103 | 5 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 186 | 103 | 5 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.22e-05 | 186 | 103 | 5 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.22e-05 | 186 | 103 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 186 | 103 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.40e-05 | 187 | 103 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-05 | 187 | 103 | 5 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.40e-05 | 187 | 103 | 5 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-05 | 187 | 103 | 5 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.59e-05 | 188 | 103 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.59e-05 | 188 | 103 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-05 | 189 | 103 | 5 | 1f4fe19e500bfedd48b1f34827a44e796f6db3e1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.78e-05 | 189 | 103 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-05 | 189 | 103 | 5 | bfa1dfc93ad33a9dbef316c0591b950d062b35eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-05 | 189 | 103 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 7.93e-05 | 98 | 103 | 4 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-05 | 190 | 103 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.98e-05 | 190 | 103 | 5 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| Computational | Genes in the cancer module 112. | 8.54e-05 | 260 | 76 | 9 | MODULE_112 | |
| Computational | Ttranslation elongation. | 1.45e-04 | 15 | 76 | 3 | MODULE_150 | |
| Computational | Neighborhood of MAPT | 1.92e-04 | 41 | 76 | 4 | GNF2_MAPT | |
| Computational | Signaling. | 2.10e-04 | 230 | 76 | 8 | MODULE_176 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.15e-04 | 50 | 76 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Neighborhood of PTPRU | 5.99e-04 | 55 | 76 | 4 | GCM_PTPRU | |
| Computational | Nitrogen metabolism. | 6.99e-04 | 25 | 76 | 3 | MODULE_343 | |
| Drug | C015407 | 2.63e-07 | 13 | 102 | 4 | CID003014226 | |
| Drug | succinyl-coenzyme A | 8.26e-07 | 166 | 102 | 8 | CID000001111 | |
| Drug | oxaloacetate | 3.10e-06 | 198 | 102 | 8 | CID000000970 | |
| Drug | fluorocitrate | 6.16e-06 | 27 | 102 | 4 | CID000107647 | |
| Drug | Ferrosanol | 7.19e-06 | 9 | 102 | 3 | CID000028366 | |
| Drug | 3-iodothyronamine | 1.41e-05 | 33 | 102 | 4 | ctd:C487948 | |
| Drug | glyoxylate | 1.46e-05 | 176 | 102 | 7 | CID000000760 | |
| Drug | rufochromomycin | 2.00e-05 | 36 | 102 | 4 | CID005323583 | |
| Drug | nucleoside X | 2.42e-05 | 13 | 102 | 3 | CID000171198 | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.73e-05 | 194 | 102 | 7 | 440_UP | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 6383_UP | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 3.07e-05 | 40 | 102 | 4 | DB01907 | |
| Drug | alpha-methylisocitrate | 3.07e-05 | 14 | 102 | 3 | CID000000513 | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 4492_UP | |
| Drug | butein; Up 200; 10uM; PC3; HG-U133A | 3.21e-05 | 199 | 102 | 7 | 582_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.32e-05 | 200 | 102 | 7 | 4173_UP | |
| Drug | Fusidic Acid-d6 | 3.73e-05 | 42 | 102 | 4 | CID000003443 | |
| Drug | triethyl lead chloride | 3.82e-05 | 15 | 102 | 3 | CID000014019 | |
| Drug | sotolon | 3.82e-05 | 15 | 102 | 3 | CID000062835 | |
| Drug | malonate | 4.39e-05 | 209 | 102 | 7 | CID000000867 | |
| Drug | amythiamicin A | 5.94e-05 | 3 | 102 | 2 | CID000198789 | |
| Drug | 6-(4'-azido-2'-nitrophenylamino)hexanoate | 5.94e-05 | 3 | 102 | 2 | CID003037768 | |
| Drug | amantadine | 6.88e-05 | 95 | 102 | 5 | CID000002130 | |
| Drug | Y base | 8.03e-05 | 19 | 102 | 3 | CID000122034 | |
| Drug | 2f4b | 8.03e-05 | 19 | 102 | 3 | CID006102812 | |
| Drug | AC1L1EVQ | 8.03e-05 | 19 | 102 | 3 | CID000002970 | |
| Drug | 2-butenedioate | 8.93e-05 | 234 | 102 | 7 | CID000000723 | |
| Drug | hydroxyl radicals | MYCBP2 ACO1 ACO2 LAP3 TUFM EEF1A1 EEF1A2 PTPN5 SLC7A1 ARSA PTPRD PTPRF GLUD1 AHCY MAP3K11 DLD ALPL | 9.14e-05 | 1341 | 102 | 17 | CID000000961 |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 9.73e-05 | 320 | 102 | 8 | ctd:C030370 | |
| Drug | 4-methoxyphenyl | 1.09e-04 | 21 | 102 | 3 | CID000137580 | |
| Drug | aspartate | 1.12e-04 | 518 | 102 | 10 | CID000000424 | |
| Drug | alpha-hydroxybutyrate | 1.17e-04 | 56 | 102 | 4 | CID000011266 | |
| Drug | 2-hydroxyisonicotinate | 1.19e-04 | 4 | 102 | 2 | CID000280756 | |
| Drug | pentenoic acid | 1.19e-04 | 4 | 102 | 2 | CID000012299 | |
| Drug | BFNU | 1.19e-04 | 4 | 102 | 2 | CID000096886 | |
| Drug | Cicloral | 1.19e-04 | 4 | 102 | 2 | CID000012628 | |
| Drug | Vanadium | 1.30e-04 | 173 | 102 | 6 | ctd:D014639 | |
| Drug | ED20 | 1.34e-04 | 58 | 102 | 4 | CID000062790 | |
| Drug | AC1L1C2F | 1.38e-04 | 110 | 102 | 5 | CID000001711 | |
| Drug | 2,3,7,8-tetrabromodibenzo-4-dioxin | 1.43e-04 | 59 | 102 | 4 | ctd:C066841 | |
| Drug | idebenone | 1.43e-04 | 59 | 102 | 4 | CID000003686 | |
| Drug | guanine derivative | 1.45e-04 | 23 | 102 | 3 | CID000129161 | |
| Drug | m189 | 1.52e-04 | 178 | 102 | 6 | CID000022230 | |
| Drug | reduced diphosphopyridine nucleotide | 1.54e-04 | 342 | 102 | 8 | CID000000928 | |
| Drug | Magnesium Chloride | 1.65e-04 | 24 | 102 | 3 | ctd:D015636 | |
| Drug | BIIE0246 | 1.65e-04 | 24 | 102 | 3 | CID005311024 | |
| Drug | ZnSO4.7H2O | 1.85e-04 | 63 | 102 | 4 | CID000062639 | |
| Drug | osmium tetroxide | 1.96e-04 | 64 | 102 | 4 | CID000030318 | |
| Drug | croconic acid | 1.97e-04 | 5 | 102 | 2 | CID000546874 | |
| Drug | cyclotene | 1.97e-04 | 5 | 102 | 2 | CID000006660 | |
| Drug | 1,3-difluoro-2-propanol | 1.97e-04 | 5 | 102 | 2 | CID000067985 | |
| Drug | gliftor | 1.97e-04 | 5 | 102 | 2 | CID000197109 | |
| Drug | AC1NUSTD | 1.97e-04 | 5 | 102 | 2 | CID005492032 | |
| Drug | 1,3-difluoroacetone | 1.97e-04 | 5 | 102 | 2 | CID000228397 | |
| Drug | fluoroacetaldehyde | 1.97e-04 | 5 | 102 | 2 | CID000073766 | |
| Drug | cinchoninic acid | 1.97e-04 | 5 | 102 | 2 | CID000010243 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 3.55e-08 | 3 | 98 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.23e-06 | 7 | 98 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.79e-05 | 163 | 98 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.31e-05 | 19 | 98 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Restless Legs Syndrome | 1.08e-04 | 5 | 98 | 2 | C0035258 | |
| Disease | Junctional Epidermolysis Bullosa | 1.62e-04 | 6 | 98 | 2 | C0079301 | |
| Disease | aortic stenosis, aortic valve calcification | 3.71e-04 | 42 | 98 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.79e-04 | 102 | 98 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | hyperinsulinism (is_implicated_in) | 7.05e-04 | 12 | 98 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | behavior | 8.22e-04 | 55 | 98 | 3 | GO_0007610 | |
| Disease | Metabolic Bone Disorder | 9.68e-04 | 14 | 98 | 2 | C0005944 | |
| Disease | Osteopenia | 1.11e-03 | 15 | 98 | 2 | C0029453 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.11e-03 | 15 | 98 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | hemorheological measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0803374 | |
| Disease | ascending aortic diameter | 1.24e-03 | 140 | 98 | 4 | EFO_0021787 | |
| Disease | atherosclerosis (is_implicated_in) | 1.27e-03 | 16 | 98 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 1.27e-03 | 16 | 98 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | fatty liver disease (is_marker_for) | 1.44e-03 | 17 | 98 | 2 | DOID:9452 (is_marker_for) | |
| Disease | obesity (biomarker_via_orthology) | 1.49e-03 | 147 | 98 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | gait measurement | 1.60e-03 | 150 | 98 | 4 | EFO_0007680 | |
| Disease | nasopharyngeal neoplasm | 1.64e-03 | 151 | 98 | 4 | EFO_0004252 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.69e-03 | 257 | 98 | 5 | DOID:10652 (is_marker_for) | |
| Disease | tonsillectomy risk measurement | 1.78e-03 | 260 | 98 | 5 | EFO_0007924 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 1.80e-03 | 19 | 98 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Multiple Epiphyseal Dysplasia | 2.00e-03 | 20 | 98 | 2 | C0026760 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 2.00e-03 | 20 | 98 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.03e-03 | 160 | 98 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Disproportionate short stature | 2.17e-03 | 77 | 98 | 3 | C0878659 | |
| Disease | disease of metabolism (implicated_via_orthology) | 2.20e-03 | 21 | 98 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Metabolic Syndrome X | 2.20e-03 | 21 | 98 | 2 | C0524620 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.43e-03 | 80 | 98 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | functional brain measurement | 2.60e-03 | 82 | 98 | 3 | EFO_0007849 | |
| Disease | cognitive function measurement | COL4A2 POLR2A ME3 MST1R PDIA6 CAMK2N1 PTPRD PTPRF NRXN1 PKHD1 HYDIN NOVA1 | 2.83e-03 | 1434 | 98 | 12 | EFO_0008354 |
| Disease | temperament and character inventory | 2.87e-03 | 24 | 98 | 2 | EFO_0004825 | |
| Disease | Malignant neoplasm of breast | FLNA FLNB ADAMTS1 ACO2 LLGL1 PTPRD G3BP2 TREML1 TOP2A HNRNPR | 3.03e-03 | 1074 | 98 | 10 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGVVGKFVEFFGPGV | 271 | P21399 | |
| TVKGGTGAIVEYHGP | 256 | Q99798 | |
| GARVSGEEIGPGAYV | 221 | Q14264 | |
| GIGVNGVLPASGVYK | 681 | Q9H2F5 | |
| GKGGALYTFVGPVLA | 921 | Q8IZF5 | |
| FKGPTGYKGEQGEVG | 191 | Q14050 | |
| EVPYGLFVGGTGTLG | 141 | Q6UVK1 | |
| GIQGRKGEPGEGAYV | 96 | Q15848 | |
| KDNPYFGAGFGLVGV | 11 | Q9Y276 | |
| GGLIDSKGYGVGTPI | 771 | P39086 | |
| SIVEKPEGGGGYQFP | 6 | P41162 | |
| FGEKGTEGDIGFPGI | 1121 | P08572 | |
| AVLGEAIFYGGEPKA | 376 | Q3I5F7 | |
| PVGKNDGAVGGVRYF | 116 | Q9UDT6 | |
| FLPGYVGGIQEGAVT | 121 | Q9UBM7 | |
| FVYGVGPKSPNAVVG | 121 | P16562 | |
| PGTFLEGVAKVGQYT | 46 | Q86Y39 | |
| LPTYKLVVVGDGGVG | 11 | O14807 | |
| YETGSIRPGVIGGSK | 66 | Q06710 | |
| GIGYFFVLQPKVVDG | 666 | Q9UHI8 | |
| PVGIAGFAAIVAYGL | 31 | Q9Y241 | |
| GYGGEEKVYIATQGP | 361 | P54829 | |
| IGTRSGAVKIYGAPG | 51 | Q15334 | |
| GAVKIYGAPGVEFTG | 56 | Q15334 | |
| VIFEVAFNGPKGGYV | 301 | Q7Z304 | |
| AKEQGTVPGFIGFGT | 26 | O94822 | |
| PLVFVGKGITFDSGG | 276 | P28838 | |
| LGGPLEKGIYFSEEG | 3151 | Q16787 | |
| SVPKEVVQLGGKGYG | 231 | Q96FI4 | |
| YFGGSEIVVAGKFDP | 521 | P19823 | |
| FYKGVAEGEVDPAFG | 506 | Q9UQ53 | |
| EGAGGRPYVVKAVAG | 1626 | Q8NDA2 | |
| ADVTLEGQVYPGKGG | 181 | Q14696 | |
| GVSAAFGAPVGGVLF | 296 | P51798 | |
| GYGGISLAVEGPSKV | 2031 | O75369 | |
| DIAVGAPFEGLGKVY | 386 | P26006 | |
| YSGVQPGIGTEVFVG | 156 | O43390 | |
| PIGIYVKTIFAGGAA | 241 | Q14005 | |
| GYGDVVPGTTAGKLT | 376 | Q9ULS6 | |
| GKGTTYEGGVREPAL | 301 | P15289 | |
| FGYKGEETPVIVGSA | 206 | P49411 | |
| VAKPSQVYFGGTVVG | 841 | P23229 | |
| DPGTTYIFSKGGGQI | 1121 | Q9ULB1 | |
| TAILYGNGPGYKVVG | 411 | P05186 | |
| RPIVGLGGGKYVSFE | 226 | Q13643 | |
| TFPKGAEGGLDFGIV | 3046 | Q4G0P3 | |
| VGVAVLGGFLYAVGG | 406 | Q9Y2M5 | |
| GLGRKPGGIYEIEFS | 31 | Q86Z20 | |
| VFPIYEGGVGEGLRG | 446 | Q9P218 | |
| GDGDSGKYAFPVGLT | 466 | Q8N8A6 | |
| YGPGIEGQGVFREAT | 1261 | P21333 | |
| TPGFGDKTFVVQGFG | 296 | P00367 | |
| GGINTSVPYGGIYVK | 966 | Q68DX3 | |
| GVGGKLPNFGFVVFD | 366 | Q9UN86 | |
| QDVYKIGGIGTVPVG | 251 | Q05639 | |
| QDVYKIGGIGTVPVG | 251 | P68104 | |
| DVTKTPGPGFGIYAV | 1486 | Q5TH69 | |
| GTVGDKAGVFPSNYV | 1041 | Q15811 | |
| VIGSGPGGYVAAIKA | 46 | P09622 | |
| YVFPGVALGVIAGGI | 491 | Q16798 | |
| VVGGPGDASVDAIYK | 1076 | Q9P267 | |
| QDVYKIGGIGTVPVG | 251 | Q5VTE0 | |
| GDDSVVIGGKPYVFD | 36 | Q12840 | |
| DTYAVEKEGGKQGGP | 251 | O15037 | |
| AAEEASGKYGGGVPL | 316 | A6NMB9 | |
| PEGKNDGSVGGVRYF | 331 | Q96DZ5 | |
| IFVVGFGLYGSIHGP | 401 | Q9BX70 | |
| GPDVFGNDVVRGYGA | 91 | Q9UPM9 | |
| IVGGGYTPSKYAVEG | 171 | Q9BPW9 | |
| IAGKVAVVAGYGDVG | 211 | P23526 | |
| ITQIPGGYVASKIGG | 121 | Q9NRA2 | |
| EVIGIGGFGKVYRGS | 121 | Q16584 | |
| GQYGVQGFPTIKIFG | 91 | Q15084 | |
| QGVPKTGEGFIDFIG | 1806 | P10586 | |
| QGVPKSGEGFIDFIG | 1811 | P23468 | |
| IPSYAAGSIIGKGGQ | 56 | P51513 | |
| GAVGPFLFRKGEVGD | 251 | Q6IMI4 | |
| EKGFGIFVEGVEPGS | 551 | Q8TEU7 | |
| GPTLGGFLYEKIGFE | 391 | Q6NT16 | |
| LQGGGYGVEKGVPTL | 256 | Q86UD5 | |
| VDKPGIVVVGFSVYG | 1751 | O75592 | |
| VVYDGGVFLGPIFGD | 881 | P08F94 | |
| RGGGGGAKQVLYVPV | 71 | O94818 | |
| PGEDKGGYVIKASEG | 526 | Q9NSD9 | |
| GVGIGGSIPIVFSYF | 266 | Q7L0J3 | |
| AATLFGYLVVPAGGG | 421 | Q96BD0 | |
| KLSPYGDGGDVGQIF | 11 | Q7Z7J9 | |
| KGQPGEYGVQGLTGF | 1386 | Q17RW2 | |
| VASGGIIGYVKAGSV | 21 | Q9P0S9 | |
| PNCGFGKTGIIDYGI | 101 | P98066 | |
| DGGFVYIAGKCGLVP | 411 | P02787 | |
| GVAAGRPYVGGLEEF | 1081 | Q99973 | |
| DVAVYGVAVPGVEGK | 536 | Q6PCB7 | |
| GLCYGEFGARVPKTG | 81 | P30825 | |
| VTEGGIKYPETTEGG | 36 | P24928 | |
| GGVIPYVIGGNFTGS | 161 | Q9Y6L7 | |
| FVGGVYGGNIKPTPF | 56 | Q8NAV1 | |
| SGLGVVGRDKYGVFP | 471 | P11388 | |
| YATVIFPGGNKGGGT | 281 | Q86YW5 | |
| AGTTGKGEVPDGYSV | 71 | A0A1B0GX49 | |
| LFGVFVTGKDGGPGV | 346 | Q04912 | |
| GKGPVYLLFSVNGSG | 451 | Q9Y5A9 | |
| GKIYATGGIVSSEGP | 821 | Q96CT2 | |
| IVPYKTIEGTARGGG | 571 | P32418 | |
| GGFTITGKYLFGQPV | 646 | P32418 |